INSIGHTS ON QUALITY CONTROL

• Inside The Cleanroom: Building A Culture Of Clean Beyond The CCS Blueprint

  Achieving sterile excellence requires more than just rigid protocols. Learn how to foster a proactive mindset across your entire organization to ensure long-term facility integrity.

• High-Throughput Pyrogen Testing In A Multimode Microplate Reader

  Explore a faster, high‑sensitivity approach to pyrogen detection that uses an NF‑κB reporter system to measure both endotoxin and non‑endotoxin contaminants to enable shorter workflows.

• Quantitative Determination Of Amorphous And Crystalline Drug In Polymer Microspheres

  Biodegradable polymer microspheres control drug release through crystalline and amorphous properties, analyzed using DSC, MDSC, and TGA to determine composition and stability for precise delivery.

• Environmental Monitoring In Advanced Therapeutic Medicinal Products Facilities

  Discover how to adapt your environmental monitoring framework to meet the distinct risk-management and regulatory needs of ATMP facility production.

• Building A Culture Of GxP Excellence In 2026—Veeva Training Solutions Podcast

  4/24/2026

  Shift from basic compliance to a strategic GxP culture. Explore how intentional, role-specific training and leadership support reduce risks and improve business outcomes in this video.

• CMO Validation As A Service

  8/20/2024

  Learn about the highly successful commissioning and qualification of Wheeler's Oklahoma City CDMO facility with the overarching goal of ensuring all equipment was qualified for a Phase 3 clinical production campaign.

• Global Regulatory Compliance For Aseptic Barrier Systems

  6/24/2026

  Reconcile differing regulatory philosophies in sterile manufacturing. Learn to use prescriptive baselines and scientific data to achieve global compliance.

• Practical Considerations For Aseptic Gowning In Contamination Control Strategies (CCS)

  2/13/2026

  Personnel remain the most significant contributor to contamination risk. Explore these practical considerations for your CCS to address complex interactions between operators and their environment

• Revolutionizing The Development, Characterization, And Manufacturing Of Peptides

  7/24/2026

  Erik Feldmann, Technical Director, on the analytical challenges of proteins, peptides, and oligonucleotides — and why he starts every method-development problem by understanding what the customer is trying to achieve.